This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

Menu

Close

AMSAMSAn introduction to antimicrobial stewardshipStewardshipSurveillanceRace against resistanceABSABSABS in practice Educational ResourcesAFSAFSShape the futureAFS in practiceImplementing an AFS programmeDiagnosticsGuidelinesCase studiesAll case studiesDisease AwarenessDisease AwarenessAspergillosisOur CommitmentOur CommitmentOur commitment to anti-infectivesHeritageSustainability
Our work in the community
Support & ResourcesSupport & ResourcesVideosMaterialsOnline LearningOnline LearningHomeINSPIRE To: Change the CourseINSPIRE To: Change the Course Season 2The global threat of carbapenemase-producing enterobacterales (CPE)CPE Epidemiology CPE Factsheet London AMS SeriesNorth West England AMS SeriesInfectious Thinking Podcasts

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

Online LearningINSPIRE To: Change the Course

Old moulds, new problems – Fungal infections in the ICU

Welcome to INSPIRE To: Change the Course S2 online learning. This is a 2-part series on managing fungal infections in the intensive care unit.

Together with leading experts, we have developed a series of short videos designed to provide you with the knowledge to be able to spot and diagnose fungal infections in the ICU, and be aware of the considerations for managing these patients. After completing each course in the series, you will be able to download a certificate of completion.

CRESEMBA® (isavuconazole) is indicated in adults for the treatment of Invasive Aspergillosis and also for the treatment of Mucormycosis in patients for whom amphotericin B is inappropriate. Consideration should be given to official guidance on the appropriate use of antifungal agents. 

Start browsing the courses below to begin your online learning, and your journey to Change the Course.

Educational resources

We have a variety of educational resources aimed at supporting healthcare professionals looking to enhance their knowledge of antimicrobial resistance and stewardship.

Access support
Loading
Dr Neil Stone

From this course you will learn about:

  • The risk factors and signs of Candidaemia infections in the ICU
  • The importance of judicious use of antifungal therapies
  • What antifungal therapies are currently available, and their potential applications, strengths and limitations


Total time to complete: 10 minutes

Start LearningLoading
Educational resources

We have a variety of educational resources aimed at supporting healthcare professionals looking to enhance their knowledge of antimicrobial resistance and stewardship.

Access support
Loading
Lisa Nwankwo

From this course you will learn about:

  • Pharmaceutical management of IA in the ICU, and key considerations when selecting treatments
  • Practical management of IA in a real-life patient case

Total time to complete: 9 minutes



 

Start Learning
Loading
Educational resources

We have a variety of educational resources aimed at supporting healthcare professionals looking to enhance their knowledge of antimicrobial resistance and stewardship.

Access support
Loading
Start your learning now

Begin the first video in the series: “Candidaemia infections in the ICU”

(3 minutes) 





 

Go to video
Loading
Educational ResourcesAccess our second module: Diagnosis and management of Invasive Fungal Infections

Click here to hear from Dr Hastie Robbie and Claire Berry  

Go to Module 2Loading
Access more antimicrobial stewardship resourcesGet further information on antimicrobial stewardship including a variety of resources for antibacterial and antifungal stewardship on the Anti-infectives section of PfizerPro

 

Visit Anti-infectives Loading

IA, invasive aspergillosis; ICU, intensive care unit.

 

Prescribing Information:

Click here for CRESEMBA® (isavuconazole)

PP-CRB-GBR-2500. July 2024

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​